Home / Metoprolol / United States
US ATC C07AB02 · updated 2 Nov 2026
Metoprolol shortage in United States
Is there a Metoprolol shortage in United States?
Yes. As of 2 Nov 2026, 7 Metoprolol products are reported short in United States, the first since 31 Aug 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Germany, Italy, Spain, Czechia, Norway, Sweden, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11) discontinuation | Teva Pharmaceuticals USA, Inc. | 31 Aug 2026 | not given | Not stated |
| US | Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96) discontinuation | Teva Pharmaceuticals USA, Inc. | 31 Aug 2026 | not given | Not stated |
| US | Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11) discontinuation | Teva Pharmaceuticals USA, Inc. | 31 Aug 2026 | not given | Not stated |
| US | Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11) discontinuation | Teva Pharmaceuticals USA, Inc. | 31 Aug 2026 | not given | Not stated |
| US | Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96) discontinuation | Teva Pharmaceuticals USA, Inc. | 31 Aug 2026 | not given | Not stated |
| US | Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11) discontinuation | Teva Pharmaceuticals USA, Inc. | 31 Aug 2026 | not given | Not stated |
| US | Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96) discontinuation | Teva Pharmaceuticals USA, Inc. | 31 Aug 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).